sur Zomedica Corp. (NASDAQ:ZOM)
Zomedica Names Scott A. Jordan as New CFO
Zomedica Corp., specializing in veterinary health, announced that Scott A. Jordan will assume the role of Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025. Bringing over 30 years of experience in life sciences and diagnostics, Jordan's move aligns with Zomedica's strategic goals.
Jordan's background includes founding S. Jordan Associates, where he facilitated capital raising and strategic partnerships. He previously held CFO roles at biotechnology firms in Texas, contributing to significant corporate milestones, including Salarius Pharmaceuticals' NASDAQ listing. Jordan's expertise is expected to support Zomedica's growth in the animal health sector.
A Michigan State graduate with an MBA from DePaul University, Jordan succeeds Peter Donato. He aims to leverage his experience to enhance shareholder value and expand Zomedica's market impact.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.